Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release SyndromeReid Rubsamen, Paul E. Harris, Christopher Massey et al.|Frontiers in Pharmacology|2020Cited by 9